|
|
Volumn 8, Issue 3, 2002, Pages 117-119
|
|
Treating heart failure: It's time for new paradigms and novel approaches
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BISOPROLOL;
BOSENTAN;
CARVEDILOL;
CYTOKINE;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL;
ENDOTHELIN RECEPTOR ANTAGONIST;
ETANERCEPT;
INOTROPIC AGENT;
METOPROLOL;
OMAPATRILAT;
SPIRONOLACTONE;
VALSARTAN;
VASODILATOR AGENT;
VASOPEPTIDASE INHIBITOR;
ADRENERGIC SYSTEM;
CLINICAL RESEARCH;
CLINICAL TRIAL;
CYTOKINE PRODUCTION;
EDITORIAL;
HEART FAILURE;
HUMAN;
MORBIDITY;
MORTALITY;
PRIORITY JOURNAL;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
SURVIVAL RATE;
CONGESTIVE HEART FAILURE;
NOTE;
PHYSIOLOGY;
HEART FAILURE, CONGESTIVE;
HUMANS;
RENIN-ANGIOTENSIN SYSTEM;
|
|
EID: 0036023201
PISSN: 10719164
EISSN: None
Source Type: Journal
DOI: 10.1054/jcaf.2002.126485 Document Type: Article |
|
Times cited : (7)
|
|
References (9)
|
